BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lovastatin
,
rs6983267
,
BRCA1
,
T cell receptor signaling pathway
,
Leukemia
,
Lung
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Equilibrative nucleoside transporter 2
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Tonsil
Tongue main corpus
Skeletal muscle
Jejunum
Extraocular muscle
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Tinea pedis
Viral enteritis
Irritable bowel syndrome
Myocardial ischemia
Measles
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Benzazepines
aceclofenac
Allylamine
Glipizide
Didanosine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MAGEB6
DEXI
CLP1
AFDN
PKM
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP Colorectal cancer HT 29 cells with gene overexpression perturbations
Umbilical vein endothelial cells with PKM2 and TP53 siRNA knockdowns
SetD8 Knockdown in ß- estradiol-treated (24 h) G1E-ER-GATA-1 cells
Colorectal cancer HT29 cells with different treatments to induce or inhibit necroptosis
Innate memory CD8+ T cells compared to homeostatically expanded CD8+ T cells
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Equilibrative nucleoside transporter 2
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Ce…
Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer
A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in P…
A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancrea…
Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ